Stay updated on Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T10:49:08.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. It indicates a minor update to the page without changing the core study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-03-08T01:48:38.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now displays revision v3.4.2; the previous revision v3.4.1 has been removed.
    Difference
    0.0%
    Check dated 2026-02-14T08:22:45.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-07T06:10:30.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added UI/metadata updates: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-24T00:57:15.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T23:53:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.